| Symbol |
Name |
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB10
|
ATP-binding cassette, sub-family B (MDR/TAP), member 10
|
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
|
|
ABCB8
|
ATP-binding cassette, sub-family B (MDR/TAP), member 8
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI2
|
abl-interactor 2
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADA
|
adenosine deaminase
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADGRE3
|
adhesion G protein-coupled receptor E3
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
AES
|
amino-terminal enhancer of split
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AGA
|
aspartylglucosaminidase
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKRD26
|
ankyrin repeat domain 26
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBB1IP
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARHGAP26
|
Rho GTPase activating protein 26
|
|
ARIH2
|
ariadne RBR E3 ubiquitin protein ligase 2
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARRB1
|
arrestin, beta 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATG4B
|
autophagy related 4B, cysteine peptidase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATP5F1
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AURKC
|
aurora kinase C
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCOR
|
BCL6 corepressor
|
|
BCORL1
|
BCL6 corepressor-like 1
|
|
BCR
|
breakpoint cluster region
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEX2
|
brain expressed X-linked 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC8
|
baculoviral IAP repeat containing 8
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLNK
|
B-cell linker
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator)
|
|
BSG
|
basigin (Ok blood group)
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTN3A1
|
butyrophilin, subfamily 3, member A1
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALCRL
|
calcitonin receptor-like
|
|
CALR
|
calreticulin
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMLG
|
calcium modulating ligand
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBX4
|
chromobox homolog 4
|
|
CCDC26
|
CCDC26 long non-coding RNA
|
|
CCDC28A
|
coiled-coil domain containing 28A
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD177
|
CD177 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD209
|
CD209 molecule
|
|
CD226
|
CD226 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300E
|
CD300e molecule
|
|
CD300LB
|
CD300 molecule-like family member b
|
|
CD300LD
|
CD300 molecule-like family member d
|
|
CD300LF
|
CD300 molecule-like family member f
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD5L
|
CD5 molecule-like
|
|
CD7
|
CD7 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD80
|
CD80 molecule
|
|
CD83
|
CD83 molecule
|
|
CD86
|
CD86 molecule
|
|
CD96
|
CD96 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC25B
|
cell division cycle 25B
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CEBPG
|
CCAAT/enhancer binding protein (C/EBP), gamma
|
|
CEBPZ
|
CCAAT/enhancer binding protein (C/EBP), zeta
|
|
CELA3B
|
chymotrypsin-like elastase family, member 3B
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHIC2
|
cysteine-rich hydrophobic domain 2
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
|
CLC
|
Charcot-Leyden crystal galectin
|
|
CLEC12A
|
C-type lectin domain family 12, member A
|
|
CLEC12B
|
C-type lectin domain family 12, member B
|
|
CLEC1A
|
C-type lectin domain family 1, member A
|
|
CLEC4D
|
C-type lectin domain family 4, member D
|
|
CLEC4G
|
C-type lectin domain family 4, member G
|
|
CLEC9A
|
C-type lectin domain family 9, member A
|
|
CLECL1
|
C-type lectin-like 1
|
|
CLU
|
clusterin
|
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTRL
|
centriolin
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
COX2
|
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSG
|
cathepsin G
|
|
CTSL
|
cathepsin L
|
|
CUEDC2
|
CUE domain containing 2
|
|
CUX1
|
cut-like homeobox 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXXC1
|
CXXC finger protein 1
|
|
CXXC5
|
CXXC finger protein 5
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4F3
|
cytochrome P450, family 4, subfamily F, polypeptide 3
|
|
DACH1
|
dachshund family transcription factor 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DCK
|
deoxycytidine kinase
|
|
DCST2
|
DC-STAMP domain containing 2
|
|
DCSTAMP
|
dendrocyte expressed seven transmembrane protein
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX18
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 18
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
|
DEFT1P
|
defensin, theta 1 pseudogene
|
|
DEK
|
DEK proto-oncogene
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DMTF1
|
cyclin D binding myb-like transcription factor 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP6
|
dipeptidyl-peptidase 6
|
|
DTNA
|
dystrobrevin, alpha
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F7
|
E2F transcription factor 7
|
|
E4F1
|
E4F transcription factor 1
|
|
EED
|
embryonic ectoderm development
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELL
|
elongation factor RNA polymerase II
|
|
ENG
|
endoglin
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EP300
|
E1A binding protein p300
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERC1
|
ELKS/RAB6-interacting/CAST family member 1
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ETNK1
|
ethanolamine kinase 1
|
|
ETV5
|
ets variant 5
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCHSD2
|
FCH and double SH3 domains 2
|
|
FERMT2
|
fermitin family member 2
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FIS1
|
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP1
|
forkhead box P1
|
|
FPR1
|
formyl peptide receptor 1
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FZD4
|
frizzled class receptor 4
|
|
FZD9
|
frizzled class receptor 9
|
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABARAPL2
|
GABA(A) receptor-associated protein-like 2
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAS2
|
growth arrest-specific 2
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GFI1B
|
growth factor independent 1B transcription repressor
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLIPR1
|
GLI pathogenesis-related 1
|
|
GLS
|
glutaminase
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
GPR84
|
G protein-coupled receptor 84
|
|
GPX3
|
glutathione peroxidase 3
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRN
|
granulin
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSX2
|
GS homeobox 2
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBP1
|
HMG-box transcription factor 1
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC6
|
histone deacetylase 6
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLX
|
H2.0-like homeobox
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOMER3
|
homer scaffolding protein 3
|
|
HOXA10
|
homeobox A10
|
|
HOXA13
|
homeobox A13
|
|
HOXA4
|
homeobox A4
|
|
HOXA6
|
homeobox A6
|
|
HOXA7
|
homeobox A7
|
|
HOXA9
|
homeobox A9
|
|
HOXA@
|
homeobox A cluster
|
|
HOXB4
|
homeobox B4
|
|
HOXD11
|
homeobox D11
|
|
HOXD13
|
homeobox D13
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH4
|
histamine receptor H4
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HTT
|
huntingtin
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER5
|
immediate early response 5
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGHM
|
immunoglobulin heavy constant mu
|
|
IGHV4-31
|
immunoglobulin heavy variable 4-31
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL17A
|
interleukin 17A
|
|
IL17D
|
interleukin 17D
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL24
|
interleukin 24
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3
|
interleukin 3
|
|
IL32
|
interleukin 32
|
|
IL36A
|
interleukin 36, alpha
|
|
IL36B
|
interleukin 36, beta
|
|
IL36G
|
interleukin 36, gamma
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KANK1
|
KN motif and ankyrin repeat domains 1
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2B
|
lysine (K)-specific demethylase 2B
|
|
KDM3B
|
lysine (K)-specific demethylase 3B
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1524
|
KIAA1524
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF3
|
Kruppel-like factor 3 (basic)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT7
|
keratin 7, type II
|
|
KSR1
|
kinase suppressor of ras 1
|
|
KSR2
|
kinase suppressor of ras 2
|
|
L2HGDH
|
L-2-hydroxyglutarate dehydrogenase
|
|
L3MBTL1
|
l(3)mbt-like 1 (Drosophila)
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LCN2
|
lipocalin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LLGL1
|
lethal giant larvae homolog 1 (Drosophila)
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LPXN
|
leupaxin
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LST1
|
leukocyte specific transcript 1
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LUC7L2
|
LUC7-like 2 (S. cerevisiae)
|
|
LY75
|
lymphocyte antigen 75
|
|
LY96
|
lymphocyte antigen 96
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEFV
|
Mediterranean fever
|
|
MEIS1
|
Meis homeobox 1
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR1-2
|
microRNA 1-2
|
|
MIR100
|
microRNA 100
|
|
MIR10A
|
microRNA 10a
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR125A
|
microRNA 125a
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR126
|
microRNA 126
|
|
MIR142
|
microRNA 142
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR150
|
microRNA 150
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR181B2
|
microRNA 181b-2
|
|
MIR181C
|
microRNA 181c
|
|
MIR193A
|
microRNA 193a
|
|
MIR193B
|
microRNA 193b
|
|
MIR196B
|
microRNA 196b
|
|
MIR199B
|
microRNA 199b
|
|
MIR20A
|
microRNA 20a
|
|
MIR212
|
microRNA 212
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR23A
|
microRNA 23a
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR27A
|
microRNA 27a
|
|
MIR27B
|
microRNA 27b
|
|
MIR29A
|
microRNA 29a
|
|
MIR30E
|
microRNA 30e
|
|
MIR31
|
microRNA 31
|
|
MIR32
|
microRNA 32
|
|
MIR326
|
microRNA 326
|
|
MIR328
|
microRNA 328
|
|
MIR337
|
microRNA 337
|
|
MIR34A
|
microRNA 34a
|
|
MIR34B
|
microRNA 34b
|
|
MIR375
|
microRNA 375
|
|
MIR378A
|
microRNA 378a
|
|
MIR424
|
microRNA 424
|
|
MIR451A
|
microRNA 451a
|
|
MIR495
|
microRNA 495
|
|
MIR564
|
microRNA 564
|
|
MIR663A
|
microRNA 663a
|
|
MIR92A1
|
microRNA 92a-1
|
|
MIRLET7A3
|
microRNA let-7a-3
|
|
MIRLET7C
|
microRNA let-7c
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MKNK2
|
MAP kinase interacting serine/threonine kinase 2
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLH1
|
mutL homolog 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
|
|
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP19
|
matrix metallopeptidase 19
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MR1
|
major histocompatibility complex, class I-related
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MSLN
|
mesothelin
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MVP
|
major vault protein
|
|
MXD1
|
MAX dimerization protein 1
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH10
|
myosin, heavy chain 10, non-muscle
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MZF1
|
myeloid zinc finger 1
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NEBL
|
nebulette
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFYB
|
nuclear transcription factor Y, beta
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NME2
|
NME/NM23 nucleoside diphosphate kinase 2
|
|
NMU
|
neuromedin U
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRBP1
|
nuclear receptor binding protein 1
|
|
NRIP3
|
nuclear receptor interacting protein 3
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NT5C2
|
5'-nucleotidase, cytosolic II
|
|
NT5C3A
|
5'-nucleotidase, cytosolic IIIA
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OIP5
|
Opa interacting protein 5
|
|
OLFM4
|
olfactomedin 4
|
|
ORM1
|
orosomucoid 1
|
|
OS9
|
osteosarcoma amplified 9, endoplasmic reticulum lectin
|
|
OSBP2
|
oxysterol binding protein 2
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARK7
|
parkinson protein 7
|
|
PAX5
|
paired box 5
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PBX3
|
pre-B-cell leukemia homeobox 3
|
|
PCM1
|
pericentriolar material 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD5
|
programmed cell death 5
|
|
PDCD7
|
programmed cell death 7
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PER2
|
period circadian clock 2
|
|
PER3
|
period circadian clock 3
|
|
PF4
|
platelet factor 4
|
|
PGP
|
phosphoglycolate phosphatase
|
|
PHF6
|
PHD finger protein 6
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIR
|
pirin (iron-binding nuclear protein)
|
|
PIWIL2
|
piwi-like RNA-mediated gene silencing 2
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2
|
|
PLK1
|
polo-like kinase 1
|
|
PLK2
|
polo-like kinase 2
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
POU4F1
|
POU class 4 homeobox 1
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PPP3R1
|
protein phosphatase 3, regulatory subunit B, alpha
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM12
|
PR domain containing 12
|
|
PRDM16
|
PR domain containing 16
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKD2
|
protein kinase D2
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PROK1
|
prokineticin 1
|
|
PROK2
|
prokineticin 2
|
|
PRTN3
|
proteinase 3
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PTBP2
|
polypyrimidine tract binding protein 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRG
|
protein tyrosine phosphatase, receptor type, G
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PVR
|
poliovirus receptor
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASGRP4
|
RAS guanyl releasing protein 4
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBM15
|
RNA binding motif protein 15
|
|
RBM6
|
RNA binding motif protein 6
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHOA
|
ras homolog family member A
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RMI1
|
RecQ mediated genome instability 1
|
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RPS14
|
ribosomal protein S14
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRB
|
retinoid X receptor, beta
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SDC1
|
syndecan 1
|
|
SDC2
|
syndecan 2
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEPT6
|
septin 6
|
|
SEPT7
|
septin 7
|
|
SEPT9
|
septin 9
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETBP1
|
SET binding protein 1
|
|
SETMAR
|
SET domain and mariner transposase fusion gene
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SKI
|
SKI proto-oncogene
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA5
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHKAP
|
SPHK1 interactor, AKAP domain containing
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SQSTM1
|
sequestosome 1
|
|
SRI
|
sorcin
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
|
SST
|
somatostatin
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSX2IP
|
synovial sarcoma, X breakpoint 2 interacting protein
|
|
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
ST7
|
suppression of tumorigenicity 7
|
|
STAG1
|
stromal antigen 1
|
|
STAG2
|
stromal antigen 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STK11
|
serine/threonine kinase 11
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUMO2
|
small ubiquitin-like modifier 2
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
TAF7L
|
TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 50kDa
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TCERG1
|
transcription elongation regulator 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TET3
|
tet methylcytosine dioxygenase 3
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TRIB1
|
tribbles pseudokinase 1
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRIP12
|
thyroid hormone receptor interactor 12
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
ULBP1
|
UL16 binding protein 1
|
|
ULBP2
|
UL16 binding protein 2
|
|
ULBP3
|
UL16 binding protein 3
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VNN2
|
vanin 2
|
|
VSTM1
|
V-set and transmembrane domain containing 1
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
|
WT1
|
Wilms tumor 1
|
|
XAB2
|
XPA binding protein 2
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZC3H15
|
zinc finger CCCH-type containing 15
|
|
ZMYND8
|
zinc finger, MYND-type containing 8
|
|
ZNF296
|
zinc finger protein 296
|
|
ZRSR2
|
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2
|
|
ZXDC
|
ZXD family zinc finger C
|
